|
[Related PubMed/MEDLINE]
Total Number of Papers: 177
|
|
|
|
|
[Display Entries]
|
|
|
| |
|
[Entries Per Page]
|
|
per page
|
| |
|
Page Control
|
|
|
|
Page: of
|
|
|
|
| Abbreviation |
: LRP |
| Long Form |
: lung resistance protein |
|
| No. |
Year |
Title |
Co-occurring Abbreviation |
| 1 |
2020 |
IOX-101 Reverses Drug Resistance Through Suppression of Akt/mTOR/NF-kappaB Signaling in Cancer Stem Cell-Like, Sphere-Forming NSCLC Cell. |
GEM, mTOR, NF-kappaB |
| 2 |
2019 |
Multidrug resistance affects the prognosis of primary epithelial ovarian cancer. |
GSTP1, MSP, PEOC, RASSF1A, RT-qPCR |
| 3 |
2018 |
Expression of multidrug-resistance associated proteins in human retinoblastoma treated by primary enucleation. |
GSTpi, ON, P-gp, Rb |
| 4 |
2018 |
Expression of resistance gene and prognosis of chemotherapy in primary epithelial ovarian cancer. |
ANCC, CPIR, GSTP1, PEOC |
| 5 |
2018 |
The close relationship between heparanase and epithelial mesenchymal transition in gastric signet-ring cell adenocarcinoma. |
EMT, HPSE, SRCA |
| 6 |
2017 |
Cisplatin induces expression of drug resistance-related genes through c-jun N-terminal kinase pathway in human lung cancer cells. |
--- |
| 7 |
2017 |
Differential expression of breast cancer-resistance protein, lung resistance protein, and multidrug resistance protein 1 in retinas of streptozotocin-induced diabetic mice. |
BCRP, BRB, DR, FITC, MDR1, VEGF-A, ZO-1 |
| 8 |
2017 |
Effect and mechanism of resveratrol on drug resistance in human bladder cancer cells. |
ADM, GST, MDR, MRP1, RES |
| 9 |
2017 |
Expression levels of resistant genes affect cervical cancer prognosis. |
CC, GSTP1, MDR |
| 10 |
2017 |
Reversal of doxorubicin-resistance by Salvia miltiorrhiza ligustrazine in the SHG44/doxorubicin glioma drug-resistant cell line. |
DOX, MDR1, MRP1, SML |
| 11 |
2016 |
Combination of gambogic acid with cisplatin enhances the antitumor effects on cisplatin-resistant lung cancer cells by downregulating MRP2 and LRP expression. |
GA, MRP2 |
| 12 |
2016 |
Prognostic implications of survivin and lung resistance protein in advanced non-small cell lung cancer treated with platinum-based chemotherapy. |
NSCLC, OS, PFS |
| 13 |
2016 |
[Synergistic Antitumor Effect of Amorphigenin Combined with Cisplatin in Human Lung Adenocarcinoma A549/DDP Cells]. |
IC50 |
| 14 |
2015 |
Annexin A1 is involved in the acquisition and maintenance of a stem cell-like/aggressive phenotype in prostate cancer cells with acquired resistance to zoledronic acid. |
ABCG2, ANXA1, CSC, EMT, FAK, FPRs, PCa, ZA |
| 15 |
2015 |
Arsenic trioxide reduces chemo-resistance to 5-fluorouracil and cisplatin in HBx-HepG2 cells via complex mechanisms. |
5-FU, HBV, HCC, HIF-1alpha, MMP, P-gp |
| 16 |
2015 |
Assessment of 99mTc-MIBI SPECT(/CT) to monitor multidrug resistance-related proteins and apoptosis-related proteins in patients with ovarian cancer: a preliminary study. |
BCRP, MDR, MDR1, MRP1, SPECT, YB-1 |
| 17 |
2015 |
Clinical significance of the resistance proteins LRP, Pgp, MRP1, MRP3, and MRP5 in epithelial ovarian cancer. |
FIGO, MRP, P-gp |
| 18 |
2015 |
High Expression of Lung Resistance Protein mRNA at Diagnosis Predicts Poor Early Response to Induction Chemotherapy in Childhood Acute Lymphoblastic Leukemia. |
MRP, RER, SER |
| 19 |
2015 |
[Effect of Peimine on ERCC1 mRNA and LRP Expressions of A549/DDP Multidrug Resistance Cell Line]. |
ERCC1, MDR |
| 20 |
2015 |
[Influence and mechanism of PinX1 gene on the chemotherapy sensitivity of nasopharyngeal carcinoma cells in response to Cisplatin]. |
PCR, PI |
| 21 |
2014 |
Binding and inhibition of drug transport proteins by heparin: a potential drug transporter modulator capable of reducing multidrug resistance in human cancer cells. |
MDR |
| 22 |
2014 |
Expression of cancer stem cell markers is more frequent in anaplastic thyroid carcinoma compared to papillary thyroid carcinoma and is related to adverse clinical outcome. |
ABC, ALDH1, ATC, CSC, MRP1, P-gp1, PTC |
| 23 |
2014 |
FLT3-ITD and MLL-PTD influence the expression of MDR-1, MRP-1, and BCRP mRNA but not LRP mRNA assessed with RQ-PCR method in adult acute myeloid leukemia. |
AML, BCRP, DFS, FLT3-ITD, MLL-PTD, mRNA, MRP-1, RR |
| 24 |
2014 |
[Study on the mechanism of reversal effect of Curcuma Wenyujin on MDR of SGC7901/VCR]. |
ADM, CWNAE, FCM, GCS, IHC, MDR, P-gp |
| 25 |
2013 |
Expression of efflux transporters in human ocular tissues. |
BCRP, HCEC, ICB, MDR1, MRP1-7 |
| 26 |
2013 |
TFPI-2 downregulates multidrug resistance protein in 5-FU-resistant human hepatocellular carcinoma BEL-7402/5-FU cells. |
5-FU, ERCC1, GST-pi, P-gp, RI, TFPI-2 |
| 27 |
2013 |
The association of glutathione S-transferase gene mutations (including GSTT1 and GSTM1) with the prognostic factors and relapse in acute lymphoblastic leukemia. |
ALL, CNS, GST, MRP, WBC |
| 28 |
2013 |
[Drug resistance proteins LRP, Pgp, MRP1, MRP3 and MRP5 in ovarian cancer patients]. |
--- |
| 29 |
2012 |
Effect of nitric oxide on the daunorubicin efflux mechanism in K562 cells. |
NO, RT-PCR, SNAP |
| 30 |
2012 |
Folate decorated dual drug loaded nanoparticle: role of curcumin in enhancing therapeutic potential of nutlin-3a by reversing multidrug resistance. |
MDR |
| 31 |
2012 |
The expression and significance of MRP1, LRP, TOPOIIbeta, and BCL2 in tongue squamous cell carcinoma. |
Bcl-2, MRP1, TopoIIbeta |
| 32 |
2012 |
[Proteins of resistance and drug resistance in ovarian carcinoma patients]. |
MRP |
| 33 |
2011 |
Expressions of topoisomerase IIalpha and BCRP in metastatic cells are associated with overall survival in small cell lung cancer patients. |
BCRP, MRP1, NSCLC, P-gp, SCLC, TOPIIalpha |
| 34 |
2011 |
Lung resistance protein and multidrug resistance protein in non-small cell lung cancer and their clinical significance. |
MRP, NSCLC |
| 35 |
2011 |
Tanshinone IIA acts via p38 MAPK to induce apoptosis and the down-regulation of ERCC1 and lung-resistance protein in cisplatin-resistant ovarian cancer cells. |
ERCC1, GST-pi, MAPK, MDR, RI |
| 36 |
2010 |
Enhanced antitumor efficacy by paclitaxel-loaded pluronic P123/F127 mixed micelles against non-small cell lung cancer based on passive tumor targeting and modulation of drug resistance. |
MDR, NSCLC, PTX |
| 37 |
2010 |
Expression of lung resistance protein and multidrug resistance-related protein (MRP1) in pediatric acute lymphoblastic leukemia. |
ALL, MDR, MRP1 |
| 38 |
2009 |
Establishment and biological analysis of the EC109/CDDP multidrug-resistant esophageal squamous cell carcinoma cell line. |
ABCG2, ESCC, GST, MDR1, MRP1 |
| 39 |
2009 |
Expression of proteins associated with therapy resistance in rhabdomyosarcoma and neuroblastoma tumour cells. |
ABC, BCRP, MDR, MRP1, NBL, RMS |
| 40 |
2009 |
Sensitization of ABCG2-overexpressing cells to conventional chemotherapeutic agent by sunitinib was associated with inhibiting the function of ABCG2. |
--- |
| 41 |
2009 |
The expression and significance of P-glycoprotein, lung resistance protein and multidrug resistance-associated protein in gastric cancer. |
MRP, P-gp, SP |
| 42 |
2009 |
[Expression and significance of P-gp/mdr1 mRNA, MRP and LRP in non-Hodgkin's lymphoma]. |
MRP, P-gp |
| 43 |
2008 |
Expression of multidrug resistance-related proteins p-glycoprotein, glutathione-s-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma. |
MDR, P-gp, PGCA, topo II |
| 44 |
2008 |
Expression of multidrug-resistance-related proteins P-glycoprotein, glutathione-S-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma. |
MDR, P-gp, PGCA, topo II |
| 45 |
2008 |
Immunohistochemical expression of multidrug resistance proteins in mature T/NK-cell lymphomas. |
BCRP, MDR, MRP-1 |
| 46 |
2008 |
Reversal effect of tyroservatide (YSV) tripeptide on multi-drug resistance in resistant human hepatocellular carcinoma cell line BEL-7402/5-FU. |
MDR, P-gp, Rh123 |
| 47 |
2008 |
[Correlations of EGFR and LRP to chemotherapy resistance and prognosis of ovarian cancer]. |
EGFR |
| 48 |
2007 |
Activity of bortezomib in adult de novo and relapsed acute myeloid leukemia. |
AML, HSCT, MRP1, P-gp |
| 49 |
2007 |
Differential effects of the immunosuppressive agents cyclosporin A, tacrolimus and sirolimus on drug transport by multidrug resistance proteins. |
BCRP, CsA, MRP-1 |
| 50 |
2007 |
Expression of multidrug resistance 1 (MDR1), multidrug resistance-related protein 1 (MRP1), lung resistance protein (LRP), and breast cancer resistance protein (BCRP) genes and clinical outcome in childhood acute lymphoblastic leukemia. |
ALL, BCRP, MDR, MDR1, MRP1 |
| 51 |
2007 |
MDR1, MRP1 and LRP expression in patients with untreated acute leukaemia: correlation with 99mTc-MIBI bone marrow scintigraphy. |
MDR, mRNA, MRP1 |
| 52 |
2007 |
TC-99m MIBI SPECT imaging in patients with lung carcinoma: is it a functional probe of multidrug resistance genes? |
MDR, mRNA, P-gp, Tc-99m MIBI, WR |
| 53 |
2007 |
The role of MDR-related proteins in the prognosis of adult acute myeloid leukaemia (AML) with normal karyotype. |
AML, CR, EFS, MDR, MRP, OS, P-gp |
| 54 |
2007 |
The roles of four multi-drug resistance proteins in hepatocellular carcinoma multidrug resistance. |
ADM, BCRP, HCC, MDR, MDR1, MRP1 |
| 55 |
2007 |
[Expression of proteins associated with multidrug resistance and resistance to chemotherapy in lung cancer]. |
MRP1, P-gp |
| 56 |
2007 |
[Expressions of LRP, GST-pi and MRP1 in acute leukemia patients and its clinical significance]. |
AL, GST-pi, MRP-1 |
| 57 |
2007 |
[Relationship between expression of apoptosis-related genes and multidrug resistance genes in lung cancer tissues and their clinical significance]. |
GST-pi, MDR, MRP, P-gp, topo II |
| 58 |
2006 |
Clinical and molecular differences between clear cell and papillary serous ovarian carcinoma. |
CCOC, GST, MRP, P-gp, PSOC |
| 59 |
2006 |
Effective therapy of experimental human malignant melanomas with a targeted cytotoxic somatostatin analogue without induction of multi-drug resistance proteins. |
MDR, MRP |
| 60 |
2006 |
Expression dynamics of drug resistance genes, multidrug resistance 1 (MDR1) and lung resistance protein (LRP) during the evolution of overt leukemia in myelodysplastic syndromes. |
MDR1, MDS, OL, OL |
| 61 |
2006 |
IAP family protein expression correlates with poor outcome of multiple myeloma patients in association with chemotherapy-induced overexpression of multidrug resistance genes. |
IAP, MDR, MM |
| 62 |
2006 |
Multidrug resistance-related phenotype and apoptosis-related protein expression in ovarian serous carcinomas. |
MDR, MRP1, P-gp |
| 63 |
2006 |
Prognostic significance of multidrug resistance gene 1 (MDR1), multidrug resistance-related protein (MRP) and lung resistance protein (LRP) mRNA expression in acute leukemia. |
MDR, MDR1, MRP |
| 64 |
2006 |
Prognostic significance of multidrug resistance-related proteins in childhood acute lymphoblastic leukaemia. |
ALL, BCRP, MDR, MRP1, P-gp |
| 65 |
2006 |
The association of increased lung resistance protein expression with acquired etoposide resistance in human H460 lung cancer cell lines. |
MDR, P-gp |
| 66 |
2006 |
[Study on the relationship among multidrug resistance factor expression of lung cancer tissues and clinicopathological characteristics in patients with lung cancer]. |
GST-pi, MDR, MRP, P-gp, topo II |
| 67 |
2006 |
[The clinical significance of P-glycoprotein, lung resistance protein and multidrug resistance related protein expressions in infiltrating breast carcinoma tissues]. |
MRP, P-gp, RFI |
| 68 |
2005 |
Cyclosporin A is a broad-spectrum multidrug resistance modulator. |
AML, BCRP, P-gp |
| 69 |
2005 |
Immunohistochemical expression of multidrug resistance proteins as a predictor of poor response to chemotherapy and prognosis in patients with nodal diffuse large B-cell lymphoma. |
DLBCL, MDR, MRP1, P-gp |
| 70 |
2005 |
MDR1 and MRP1 gene expression are independent predictors for treatment outcome in adult acute myeloid leukaemia. |
AML, FLT3, MDR |
| 71 |
2005 |
Multidrug resistance markers P-glycoprotein, multidrug resistance protein 1, and lung resistance protein in non-small cell lung cancer: prognostic implications. |
MRP1, NSCLC, P-gp, RT-PCR |
| 72 |
2005 |
The prognostic significance of P-glycoprotein, multidrug resistance-related protein 1 and lung resistance protein in pediatric acute lymphoblastic leukemia: a retrospective study of 295 newly diagnosed patients by the Children's Oncology Group. |
ALL, MDR, MRP1, P-gp |
| 73 |
2005 |
[Expression of lung resistance protein and multidrug resistance-associated protein in naive childhood acute leukemia and their clinical significance]. |
ALL, ANLL, CR, MRP, RT-PCR |
| 74 |
2005 |
[Hypoxia-inducible factor-1 alpha dependent expression and significance of the related multidrug resistance genes induced by hypoxia in human hepatocarcinoma cell]. |
HIF-1alpha |
| 75 |
2005 |
[The effect of tetrandrine on the expression of the P170, LRP and TOPO II in S180's tumor cell induced by chemotherapy in the mice with acquired multi-drug resistance]. |
--- |
| 76 |
2004 |
CD34+ cells from acute myeloid leukemia, myelodysplastic syndromes, and normal bone marrow display different apoptosis and drug resistance-associated phenotypes. |
AML, BM, MDR, MRP, P-gp |
| 77 |
2004 |
Correlation of expression of multidrug resistance protein and messenger RNA with 99mTc-methoxyisobutyl isonitrile (MIBI) imaging in patients with hepatocellular carcinoma. |
MIBI, mRNA, MRP, P-gp |
| 78 |
2004 |
Expression of multidrug resistance-related markers in primary neuroblastoma. |
MRP, P-gp, SP |
| 79 |
2004 |
Expression of the neural cell adhesion molecule CD56 is not associated with P-glycoprotein overexpression in core-binding factor acute myeloid leukemia. |
AML, BCRP, CBF, MDR, MRP-1, P-gp |
| 80 |
2004 |
Heterogeneity in the expression of markers for drug resistance in brain tumors. |
MGMT, P-gp |
| 81 |
2004 |
Highly refractory acute myeloid leukemia. |
AML, CR, P-gp |
| 82 |
2004 |
In vitro drug-resistance profile in infant acute lymphoblastic leukemia in relation to age, MLL rearrangements and immunophenotype. |
2-CdA, ALL, HOO, L-ASP, PRED |
| 83 |
2004 |
Multidrug resistant proteins: P-glycoprotein and lung resistance protein expression in retinoblastoma. |
MDR |
| 84 |
2004 |
Multiple drug resistance protein (MDR-1), multidrug resistance-related protein (MRP) and lung resistance protein (LRP) gene expression in childhood acute lymphoblastic leukemia. |
CALLA, MRP, RT-PCR |
| 85 |
2004 |
[Coexpression and clinical significance of multi-drug resistance factors in lung cancer]. |
MRP, P-gp |
| 86 |
2004 |
[Predictive value of drug resistance-related genes expression in neoadjuvant chemotherapy in patients with non-small cell lung cancer of stage III]. |
MDR, MRP, NSCLC, P-gp |
| 87 |
2004 |
[The effect of matrine on the expression of P170 LRP and TOPO II of obtained multi-drug resistance of mouse S180's tumour cell]. |
--- |
| 88 |
2003 |
C(H)OP refractory chronic lymphocytic leukemia patients in whom salvage chemotherapy chosen by evaluating multiple chemotherapeutic drug-resistant factors was remarkably effective. |
CHOP, CLL, COP, GP, GST-Pi, MRP |
| 89 |
2003 |
Chemo- and radiation sensitivity of xenografted acute lymphoblastic leukemias--correlation to the expression of multidrug resistance proteins. |
P-gp |
| 90 |
2003 |
Comparison of two in vitro dendritic cell maturation models for screening contact sensitizers using a panel of methacrylates. |
CO, DC, GM-CSF, IL-4, P-gp, SDS |
| 91 |
2003 |
Different effects of metabolic inhibitors and cyclosporin A on daunorubicin transport in leukemia cells from patients with AML. |
AML, CyA, DNR, MI, MRP, P-gp, RT-PCR |
| 92 |
2003 |
Evaluation of MDR1, LRP, MRP, and topoisomerase IIalpha gene mRNA transcripts before and after interferon-alpha, and correlation with the mRNA expression level of the telomerase subunits hTERT and TEP1 in five unselected human melanoma cell lines. |
hTERT, MDR, MRP, RT-PCR, topo IIalpha |
| 93 |
2003 |
Expression of drug resistance related proteins in sarcomas of the pulmonary artery and poorly differentiated leiomyosarcomas of other origin. |
MRP, MT, P-gp, SPA |
| 94 |
2003 |
Expression of MRP1, LRP and Pgp in breast carcinoma patients treated with preoperative chemotherapy. |
P-gp |
| 95 |
2003 |
LRP overexpression in monocytic lineage. |
AML, ICC |
| 96 |
2003 |
Multidrug resistance in hematological malignancy. |
ARA, BCRP, MRP, P-Gp, TAP |
| 97 |
2003 |
Vascular and parenchymal mechanisms in multiple drug resistance: a lesson from human epilepsy. |
AEDs, CNS, EC |
| 98 |
2003 |
[Expression and significance of MRP, GST-pi, Topo IIalpha, and LRP in gastric carcinoma]. |
GST-pi, MDR, MRP, topo IIalpha |
| 99 |
2003 |
[Expression of lung resistance protein and multidrug resistance protein genes in bone marrow cells of acute leukemia patients and its clinical significance]. |
CR, MRP, RT-PCR |
| 100 |
2003 |
[Expression of P-glycoprotein and lung resistance protein in breast carcinoma and its relationship with prognosis]. |
P-gp |
|
A Search Service for Abbreviation / Long Form
